NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Cytotoxic


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Findings from I.Z. Mamedov and co-authors provide new insights into ankylosing spondylitis
2009 NOV 25 ... were shown to belong to the proinflammatory CD27-/CD28- population. Their potentially cytotoxic status was confirmed by staining with perforin-specific antibodies. Search for the TCR V ...
Subject: Ankylosing Spondylitis
Price: $3.00
*
Reports from G. Zelinskyy and co-researchers add new data to research in virology
2009 NOV 24 ... "Cytotoxic CD8(+) T cells control acute viremia in many viral infections. However, most viruses ...
Subject: Virology
Price: $3.00
*
Reports outline parasitology study results from State University of New York
2009 NOV 24 ... a neutral red uptake assay. demonstrated that QPX produces virulence factors that are cytotoxic to M. mercenaria haemocytes. This cytotoxicity appears to be induced by clam factors, ...
Subject: Parasitology
Price: $3.00
*
Research from Chungbuk National University, Institute of Veterinary Medicine has provided new data on life sciences
2009 NOV 23 ... of hepatic CYP2B, which metabolizes cyclophosphamide into teratogenic acrolein and cytotoxic phosphoramide mustard. Moreover, PBO remarkably attenuated cyclophosphamide-induced body ...
Subject: Life Sciences
Price: $3.00
*
Research from Radboud University in the area of life sciences published
2009 NOV 23 ... "Targeted treatment has substantially changed the field of oncology. Compared with cytotoxic chemotherapy, many novel targeted therapies are administered over long periods of time, ...
Subject: Life Sciences
Price: $3.00
*
Research from S.K. Pavelic and co-researchers in the area of gene therapy described
2009 NOV 23 ... mitosis. This study demonstrates that adenovirally mediated p53 overexpression at sub-cytotoxic levels enhanced the activity of low doses of cisplatin and methotrexate in HEp-2 and CAL ...
Subject: Gene Therapy
Price: $3.00
*
Research from Southeast University in the area of Asian research described
2009 NOV 24 ... to nanoparticles depositing in the brain tissues. Therefore, we investigated the cytotoxic effects of TiO2 NPs on microglia N9 cells in vitro. Results of propidium ...
Subject: Asian Research
Price: $3.00
*
Research from Uppsala University broadens understanding of cancer gene therapy
2009 NOV 23 ... control mice but the tumor-infiltrating effector T cells in AdCD40L-treated mice were cytotoxic (CD107a+) in contrast to those in control-treated tumors. Furthermore, AdCD40L gene ...
Subject: Cancer Gene Therapy
Price: $3.00
*
Research on breast cancer reported by scientists at National Institutes of Health
2009 NOV 23 ... purification, and characterization of Affitoxin-a novel class of HER2-specific cytotoxic molecules combining HER2-specific Affibody molecule as a targeting moiety and PE38KDEL, ...
Subject: Breast Cancer
Price: $3.00
*
Research on drug development reported by scientists at Cleveland Clinic
2009 NOV 23 ... material. A material that has a reduced systemic toxicity will allow higher doses of cytotoxic drugs to be delivered to the tumor with reduced side effects. Preliminary experiments ...
Subject: Drug Development
Price: $3.00
*
Research results from University of Tehran, Medical Department update understanding of cancer vaccines
2009 NOV 23 ... the tumor site. Tumor growth was monitored, and 2 weeks after DC immunotherapy, the cytotoxic activity and the infiltration of CD8(+) T cells were monitored in different groups. ...
Subject: Cancer Vaccines
Price: $3.00
*
Researchers from National Institutes of Health report on findings in cell therapy
2009 NOV 23 ... progressive disease after prior surgical resections, high dose interleukin-2. and anti-cytotoxic T lymphocyte antigen-4 antibody received sequential treatments with autologous tumor ...
Subject: Cell Therapy
Price: $3.00
*
Researchers from National University publish findings in life sciences
2009 NOV 23 ... length. After NIR triggered drug release, the released Pt compounds were observed to be cytotoxic, while remaining nanoparticles did not exhibit any cytotoxicity," wrote M.C. Tan and ...
Subject: Life Sciences
Price: $3.00
*
Researchers from Okayama University detail new studies and findings in the area of cardiology
2009 NOV 23 ... amount of 4-hydroxy-2-nonenal (FINE), which is a major lipid peroxidation product and a cytotoxic aldehyde, is increased in the human failing myocardium. This study was designed to ...
Subject: Cardiology
Price: $3.00
*
Scientists at Third Military Medical University discuss research in immunotherapy
2009 NOV 23 ... Immunology Immunotherapy (Identification and modification of an HLA-A*0201-restricted cytotoxic T lymphocyte epitope from Ran antigen. Cancer Immunology Immunotherapy, ...
Subject: Immunotherapy
Price: $3.00
*
Scientists at University of Amsterdam target restenosis
2009 NOV 23 ... of in-stent restenosis and late stent thrombosis is intuitively favored over the use of cytotoxic or cytostatic drugs released from a drug-eluting stent (DES). Promoting accelerated ...
Subject: Restenosis
Price: $3.00
*
Studies from S. Ash and colleagues yield new information about neuroblastoma
2009 NOV 23 ... neuroblastoma (NB), a tumor that relapses at high rates following high-dose conventional cytotoxic therapy and autologous bone marrow cell (BMC) reconstitution. This study presents a ...
Subject: Neuroblastoma
Price: $3.00
*
Studies in the area of life sciences reported from Chulalongkorn University
2009 NOV 23 ... Both extracts at a final concentration of 2.5, 5, 10, or 20 mg/plate exhibited only mild cytotoxic effects. The plant extracts at the concentrations of 2.5, 5 and 10 mg/plate in the ...
Subject: Life Sciences
Price: $3.00
*
Study data from Sichuan University provide new insights into breast cancer
2009 NOV 23 ... of ADM (0.5 mu g/mL) combined with 0.1, 1, or 10 mu g/mL TRAIL had a synergistic cytotoxic effect on MCF-7 cells, which was more marked with the combination of TRAIL (0.1 mu g/mL) ...
Subject: Breast Cancer
Price: $3.00
*
Study results from G. Konjevic and colleagues update understanding of membrane biology
2009 NOV 24 ... of receptors on NK cells and their subsets was analyzed by flow cytometry. The cytotoxic CD3(-)CD16(bright) NK subset constituted 78.97%, while the regulatory CD3(-)CD16(dim) NK ...
Subject: Membrane Biology
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login